- Botanically synthesized
- Chemically synthesized
Canine Oral Chewable Tablets Market size was valued at USD X million in 2022 and is poised to grow at a CAGR of x% from 2023 - 2029. Canine Oral Chewable Tablets Market is an oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and flea infections, and among others. Various additives and flavoring agents are used in the formulation of canine oral chewable tablets to mask the unpleasant taste and odor of the drugs. The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately. The global canine oral chewable tablets market is in the developing stage as several local and international players are actively engaged in the manufacturing of canine oral chewable tablets for the treatment of chronic canine diseases. Acquisitions and mergers, collaborations, joint ventures, and product launches, are some key strategies followed by the manufacturers for increasing their share in the global market.
Canine Oral Chewable Tablets Market Key Developments:
- in May 2014, Merck Animal Health received the FDA approval for its drug Bravecto (fluralaner) used in the treatment of fleas and ticks infections. Moreover,
- in December 2014, Putney, Inc. launched the Carprofen canine oral chewable tablets for the treatment of pain and inflammation.
Global Canine Oral Chewable Tablets Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
X%
Largest Market
Asia-Pacific
Fastest Growing Market
North America
Canine Oral Chewable Tablets Market Dynamics
Rise in the expenditure in animal welfare and wellness, wider availability of the canine oral chewable tablets in the market, and rise in the prevalence of various canine diseases such as tick and fleas infections, anticipated to fuel the global market over the forecast period. In addition, ease of administration of tablets compared with parenteral formulations, lack of nutrition values in the canine feed, and initiations taken by various pet organizations and NGOs for animal welfare are expected bolster the canine oral chewable tablets market over the forecast years. However, stringent regulatory policies for the approval of veterinary formulations, lack of awareness about the canine oral chewable tablets in rural areas, high cost of the products, and withdrawn of drugs from the market such as levothyroxine sodium due to FDA warning regarding the lack of approval might hinder the global market growth in the coming future.
North-America Got Significant Share
Canine Oral Chewable Tablets Market Regional Analysis
Geographically, canine oral chewable tablets market is segmented into the following regions Viz. Europe, Latin America, Asia Pacific, North America, and the Middle East and Africa. North America holds a significant share in global canine oral chewable tablets owing to increase in the adoption of canines (according to American Pet Products Association, approximately 78 Mn canines were owned in the U.S.), rise in the awareness of canines health, growth in the expenditure on animal welfare, increase in the research and development activities for the innovation of new products for chronic canine diseases might fuel the in the region. Asia Pacific accounts for key share, which is attributed to increasing in the prevalence of various canine microbial diseases due to unhygienic conditions, a rise in the expenditure on animal welfare, and diversification of business segment in Asia Pacific region by various manufacturers might bolster the canine oral chewable tablets market in Asia Pacific region. Europe holds a major share owing to increase the awareness about pets health, a rise in the prevalence of various canine diseases, lack of nutrition fortified canine feed, and rise in research and development activities for the canine oral chewable tablets market might propel the market growth in Europe region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Canine Oral Chewable Tablets Market Segmentation
By composition type
By Application
- Gastrointestinal diseases
- Cardiovascular disorders
- Infectious diseases
- Nutritional supplements
- Others
By Distribution Channel
- Veterinary clinics
- Veterinary Pharmacies
- Online veterinary stores
- Others
Frequently Asked Questions
The Canine Oral Chewable Tablets Market size was valued at USD x million in 2022
The Canine Oral Chewable Tablets Market key players are: Zoetis, Inc. (Pfizer) (U.S) Virbac AH Inc. (France) Elanco (Eli Lilly and Co.) (U.S.) Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany) Pala-Tech Laboratories (U.S.) Bayer HealthCare LLC, (Bayer AG) (Germany) Merck Animal Health (Merck &co. Inc.) (U.S.) Putney, Inc. (Dechra Pharmaceuticals) (U.K.)
The Canine Oral Chewable Tablets Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive summary
2. Global Canine Oral Chewable Tablets Market Introduction
2.1. Global Canine Oral Chewable Tablets Market Taxonomy
2.2. Global Canine Oral Chewable Tablets Market Definitions
2.2.1. Composition Type
2.2.2. Drug Class
3. Global Canine Oral Chewable Tablets Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Canine Oral Chewable Tablets Market Dynamics Factors Impact Analysis
3.6. Global Canine Oral Chewable Tablets Market Recent Market Introductions
4. Global Canine Oral Chewable Tablets Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Canine Oral Chewable Tablets Market Forecast, By Composition Type, 2018 - 2022 and Forecast, 2023 - 2029
5.1. Botanically Synthesized
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Chemically Synthesized
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Canine Oral Chewable Tablets Market Forecast, By Drug Class, 2018 - 2022 and Forecast, 2023 - 2029
6.1. Analgesics
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Anti-infective
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Anti-ulcers
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Vitamins & Minerals
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Cardiovascular Drugs
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
7. Global Canine Oral Chewable Tablets Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029
7.1. Gastrointestinal Diseases
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Cardiovascular Disorders
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Disorders
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Cardiovascular Disorders
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Canine Oral Chewable Tablets Market Forecast, By Distribution Channel, 2018 - 2022 and Forecast, 2023 - 2029
8.1. Veterinary Clinics
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Veterinary Pharmacies
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Online Veterinary Pharmacies
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Canine Oral Chewable Tablets Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Region, 2023 - 2029
10. North America Canine Oral Chewable Tablets Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
10.1. Composition Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.1. Botanically Synthesized
10.1.2. Chemically Synthesized
10.2. Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Analgesics
10.2.2. Anti-infective
10.2.3. Anti-ulcers
10.2.4. Vitamins & Minerals
10.2.5. Cardiovascular Drugs
10.2.6. Others
10.3. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Gastrointestinal Diseases
10.3.2. Cardiovascular Disorders
10.3.3. Infectious Diseases
10.3.4. Nutritional Supplements
10.3.5. Others
10.4. Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Veterinary Clinics
10.4.2. Veterinary Pharmacies
10.4.3. Online Veterinary Pharmacies
10.4.4. Others
10.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2023 - 2029
10.7. North America Canine Oral Chewable Tablets Market Dynamics Trends
11. Europe Canine Oral Chewable Tablets Market Analysis, 2023 - 2029 and Forecast, 2023 - 2029
11.1. Composition Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1. Botanically Synthesized
11.1.2. Chemically Synthesized
11.2. Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Analgesics
11.2.2. Anti-infective
11.2.3. Anti-ulcers
11.2.4. Vitamins & Minerals
11.2.5. Cardiovascular Drugs
11.2.6. Others
11.3. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Gastrointestinal Diseases
11.3.2. Cardiovascular Disorders
11.3.3. Infectious Diseases
11.3.4. Nutritional Supplements
11.3.5. Others
11.4. Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Veterinary Clinics
11.4.2. Veterinary Pharmacies
11.4.3. Online Veterinary Pharmacies
11.4.4. Others
11.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2023 - 2029
11.7. Europe Canine Oral Chewable Tablets Market Dynamics Trends
12. Asia-Pacific Canine Oral Chewable Tablets Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
12.1. Composition Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1. Botanically Synthesized
12.1.2. Chemically Synthesized
12.2. Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Analgesics
12.2.2. Anti-infective
12.2.3. Anti-ulcers
12.2.4. Vitamins & Minerals
12.2.5. Cardiovascular Drugs
12.2.6. Others
12.3. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gastrointestinal Diseases
12.3.2. Cardiovascular Disorders
12.3.3. Infectious Diseases
12.3.4. Nutritional Supplements
12.3.5. Others
12.4. Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Veterinary Clinics
12.4.2. Veterinary Pharmacies
12.4.3. Online Veterinary Pharmacies
12.4.4. Others
12.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2023 - 2029
12.7. Asia-Pacific Canine Oral Chewable Tablets Market Dynamics Trends
13. Latin America Canine Oral Chewable Tablets Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
13.1. Composition Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1. Botanically Synthesized
13.1.2. Chemically Synthesized
13.2. Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Analgesics
13.2.2. Anti-infective
13.2.3. Anti-ulcers
13.2.4. Vitamins & Minerals
13.2.5. Cardiovascular Drugs
13.2.6. Others
13.3. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Gastrointestinal Diseases
13.3.2. Cardiovascular Disorders
13.3.3. Infectious Diseases
13.3.4. Nutritional Supplements
13.3.5. Others
13.4. Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Veterinary Clinics
13.4.2. Veterinary Pharmacies
13.4.3. Online Veterinary Pharmacies
13.4.4. Others
13.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2023 - 2029
13.7. Latin America Canine Oral Chewable Tablets Market Dynamics Trends
14. Middle East & Africa Canine Oral Chewable Tablets Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
14.1. Composition Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.1. Botanically Synthesized
14.1.2. Chemically Synthesized
14.2. Drug Class Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Analgesics
14.2.2. Anti-infective
14.2.3. Anti-ulcers
14.2.4. Vitamins & Minerals
14.2.5. Cardiovascular Drugs
14.2.6. Others
14.3. Application Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Gastrointestinal Diseases
14.3.2. Cardiovascular Disorders
14.3.3. Infectious Diseases
14.3.4. Nutritional Supplements
14.3.5. Others
14.4. Distribution Channel Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Veterinary Clinics
14.4.2. Veterinary Pharmacies
14.4.3. Online Veterinary Pharmacies
14.4.4. Others
14.5. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2023 - 2029
14.7. MEA Canine Oral Chewable Tablets Market Dynamics Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Zoetis, Inc. (Pfizer) (U.S)
15.2.2. Virbac AH Inc. (France)
15.2.3. Elanco (Eli Lilly and Co.) (U.S.)
15.2.4. Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)
15.2.5. Pala-Tech Laboratories (U.S.)
15.2.6. Bayer HealthCare LLC, (Bayer AG) (Germany)
15.2.7. Merck Animal Health (Merck &co. Inc.) (U.S.)
15.2.8. Putney, Inc. (Dechra Pharmaceuticals) (U.K.)
16. Research Methodology
17. Key Assumptions and Acronyms
- Zoetis, Inc. (Pfizer) (U.S)
- Virbac AH Inc. (France)
- Elanco (Eli Lilly and Co.) (U.S.)
- Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)
- Pala-Tech Laboratories (U.S.)
- Bayer HealthCare LLC, (Bayer AG) (Germany)
- Merck Animal Health (Merck &co. Inc.) (U.S.)
- Putney, Inc. (Dechra Pharmaceuticals) (U.K.)